Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.
Nature. 2018 Jun;558(7709):307-312. doi: 10.1038/s41586-018-0178-z. Epub 2018 May 30.
Nature. 2018.
PMID: 29849141
Free PMC article.